Replies to post #20147 on RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

I agree. They would know if they had procedural mush, and I think they would have had to disclose it. So I do not believe that the RD2 problems occurred in RD1, or at least, not to the same extent if at all. But that may be all that they are sure of at the moment.

NeuroInvestment